| Year | Paper |
|---|---|
| 2009 | Aebersold R, Auffray C, ..., Superti-Furga G, et al. Report on EU-USA workshop: how systems biology can advance cancer research. Mol Oncol, 2009 Feb;3(1):9-17. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19383362 |
| 2009 | Amir S, Binder CJ. Experimental immunotherapeutic approaches for atherosclerosis. Clin Immunol, Epub 2009 Aug 8. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19666239 |
| 2009 | Barlow DP. Non-coding RNAs: A higher level of genome encoded information. RNA Biol, 2009 Apr;6(2):93. Editorial. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19885992 |
| 2009 | Bochkov VN, Oskolkova OV, Birukov KG, Levonen AL, Binder CJ, Stöckl J. Generation and biological activities of oxidized phospholipids. Antioxid Redox Signal, Epub 2009 Aug 17. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19686040 |
| 2009 | Brehme M, Hantschel O, Colinge J, Kaupe I, Planyavsky M, Köcher T, Mechtler K, Bennett KL, Superti-Furga G. Charting the molecular network of the drug target Bcr-Abl. Proc Natl Acad Sci USA, 2009 May 5;106(18): 7414-9. Epub 2009 Apr 20. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19380743 |
| 2009 | Brehme M. Intercell – accelerating innovation. N Biotechnol, 2009 Apr;25(4):181-4. Epub 2009 Feb 21. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19429533 |
| 2009 | Bürckstümmer T, Baumann C, Blüml S, Dixit E, Dürnberger G, Jahn H, Planyavsky M, Bilban M, Colinge J, Bennett KL, Superti-Furga G. An orthogonal proteomic-genomic screen identififies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol, 2009 Mar;10(3):266-72. Epub 2009 Jan 21. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19158679 |
| 2009 | Buxhofer-Ausch V, Gisslinger H, Berg T, Gisslinger B, Kralovics R. Acquired resistance to interferon alpha therapy associated with homozygous MPL-W515L mutation and chromosome 20q deletion in primary myelofifibrosis. Eur J Haematol, 2009 Feb;82(2):161-3. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19018861 |
| 2009 | Chou MY, Fogelstrand L, Hartvigsen K, Hansen LF, Woelkers D, Shaw PX, Choi J, Perkmann T, Bäckhed F, Miller YI, Hörkkö S, Corr M, Witztum JL, Binder CJ. Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Invest, 2009 May;119(5):1335-49. Epub 2009 Apr 13. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19363291 |
| 2009 | Fernbach NV, Planyavsky M, Müller A, Breitwieser FP, Colinge J, Rix U, Bennett KL. Acid elution and one-dimensional shotgun analysis on an orbitrap mass spectrometer – an application to drug affifinity chromatography. J 2009 Oct;8(10):4753-65.Proteome Res,. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19653696 |
| 2009 | Gröger M, Pasteiner W, Ignatyev G, Matt U, Knapp S, Atrasheuskaya A, Bukin E, Friedl P, Zinkl D, Hofer-Warbinek R, Zacharowski K, Petzelbauer P, Reingruber S. Peptide Bbeta (15-42) preserves endothelial barrier function in shock. PLoS ONE, 2009;4(4): e5391. Epub 2009 Apr 29. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19401765 |
| 2009 | Habjan M, Pichlmair A, Elliott RM, Overby AK, Glatter T, Gstaiger M, Superti-Furga G, Unger H, Weber F. NSs protein of rift valley fever virus induces the specific degradation of the double stranded RNA-dependent protein kinase. J Virol, 2009 May;83(9):4365-75. Epub 2009 Feb 11. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19211744 |
| 2009 | Hartvigsen K, Chou MY, Hansen LF, Shaw PX, Tsimikas S, Binder CJ, Witztum JL. The role of innate immunity in atherogenesis. J Lipid Res, 2009 Apr;50 Suppl:S388-93. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19106070 |
| 2009 | Hoshida Y, Nijman SM, Kobayashi M, Chan JA, Brunet JP, Chiang DY, Villanueva A, Newell P, Ikeda K, Hashimoto M, Watanabe G, Gabriel S, Friedman SL, Kumada H, Llovet JM, Golub TR. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res, 2009 Sep 15; 69(18):7385-92. Epub 2009 Sep 1. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19723656 |
| 2009 | Karayel E, Bürckstümmer T, Weitzer S, Martinez J, Superti-Furga G. The TLR independent DNA recognition pathway in murine macrophages: Ligand features and molecular signature. Eur J Immunol, 2009 Jul;39(7):1929-36. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19551900 |
| 2009 | Kelly JA, Griffifin ME, Fava RA, Wood SG, Bessette KA, Miller ER, Huber SA, Binder CJ, Witztum JL, Morganelli PM. Inhibition of arterial lesion progression in CD16-defificient mice: evidence for altered immunity and the role of IL-10. Cardiovasc Res, Epub 2009 Sep 19. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19720605 |
| 2009 | Koerner MV, Pauler FM, Huang R, Barlow DP. The function of non-coding RNAs in genomic imprinting. Development, 2009 Jun;136(11): 1771-83. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19429783 |
| 2009 | Lagler H, Sharif O, Haslinger I, Matt U, Stich K, Furtner T, Doninger B, Schmid K, Gattringer R, de Vos AF, Knapp S. TREM-1 activation alters the dynamics of pulmonary IRAK-M expression in vivo and improves host defense during pneumococcal pneumonia. J Immunol, 2009 Aug;183(3): 2027-36. Epub 2009 Jul 13. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19596984 |
| 2009 | Latos PA, Barlow DP. Regulation of imprinted expression by macro non-coding RNAs. RNA Biol, 2009 Apr;6(2):100-6. Epub 2009 Apr 14. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19229135 |
| 2009 | Latos PA, Stricker SH, Steenpass L, Pauler FM, Huang R, Senergin BH, Regha K, Koerner MV, Warczok KE, Unger C, Barlow DP. An in vitro ES cell imprinting model shows that imprinted expression of the Igf2r gene arises from an allelespecifific expression bias. Development, 2009 Feb;136(3):437-48 (Featured article). Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19141673 |
| 2009 | Lutz HU, Binder CJ, Kaveri S. Naturally occurring auto-antibodies in homeostasis and disease. Trends Immunol, 2009 Jan;30(1):43-51. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19058756 |
| 2009 | Matt U, Warszawska JM, Bauer M, Dietl W, Mesteri I, Haslinger I, Schabbauer G, Perkmann T, Binder CJ, Reingruber S, Petzelbauer P, Knapp S. B15-42 protects against acid-induced acute lung injury and secondary Pseudomonas pneumonia in vivo. Am J Respir Crit Care Med, 2009 Dec;180(12):1208-17. Epub 2009 Sep 17. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19762562 |
| 2009 | Moser C, Pohl G, Haslinger I, Knapp S, Rowczenio D, Russel T, Lachmann HJ, Lang U, Kovarik J. Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation. Nephrol Dial Transplant, 2009 Feb;24(2):676-8. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19033248 |
| 2009 | Olcaydu D, Harutyunyan A, Jäger R, Berg T, Gisslinger B, Pabinger I, Gisslinger H, Kralovics R. A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms. Nature Genetics, 2009 41(4):450-4. Epub 2009 Mar 15. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19287385 |
| 2009 | Olcaydu D, Skoda RC, Looser R, Li S, Cazzola M, Pietra D, Passamonti F, Lippert E, Carillo S, Girodon F, Vannucchi A, Reading NS, Prchal JT Ay C, Pabinger I, Gisslinger H, Kralovics R. The GGCC haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation positive polycythemia vera. Leukemia, 2009 Oct;23(10):1924-6. Epub 2009 May 14. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19440215 |
| 2009 | Pauler FM, Sloane MA, Huang R, Regha K, Koerner MV, Tamir I, Sommer A, Aszodi A, Jenuwein T, Barlow DP. H3K27me3 forms BLOCs over silent genes and intergenic regions and specifies a histone banding pattern on a mouse autosomal chromosome. Genome Res, 2009 Feb;19(2):221-33. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19047520 |
| 2009 | Perne A, Muellner MK, Steinrueck M, Craig- Mueller N, Mayerhofer J, Schwarzinger I, Sloane M, Uras IZ, Hoermann G, Nijman SM, Mayerhofer M. Cardiac glycosides induce cell death in human cells by inhibiting general protein synthesis. PLoS One, 2009 Dec 16; 4(12):e8292. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20016840 |
| 2009 | Pichlmair A, Schulz O, Tan CP, Rehwinkel J, Kato H, Takeuchi O, Akira S, Way M, Schiavo G, Reis e Sousa C. Activation of MDA5 requires higher-order RNA structures generated during virus infection. J Virol, 2009 Oct;83(20):10761-9. Epub 2009 Aug 5. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19656871 |
| 2009 | Remsing Rix LL, Rix U, Colinge J, Hantschel O, Bennett KL, Stranzl T, Müller A, Baumgartner C, Valent P, Augustin M, Till JH, Superti-Furga G. Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells. Leukemia, 2009 Mar;23(3):477-85. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19039322 |
| 2009 | Rix U, Remsing Rix LL, Terker AS, Fernbach NV, Hantschel O, Planyavsky M, Breitwieser FP, Herrmann H, Colinge J, Bennett KL, Augustin M, Till JH, Heinrich MC, Valent P, Superti-Furga G. A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profifiling and chemical proteomics in chronic myeloid leukemia cells. Leukemia, Epub 2009 Nov 5. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19890374 |
| 2009 | Rix U, Superti-Furga G. Target profiling of small molecules by chemical proteomics. Nat Chem Biol, 2009 Sep;5(9):616-24. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19690537 |
| 2009 | Schaub FX, Jäger R, Looser R, Hao-Shen H, Hermouet S, Girodon F, Tichelli A, Gisslinger H, Kralovics R, Skoda RC. Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F. Blood, 2009 Feb;113(9):2022-7. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19047681 |
| 2009 | Schwartz-Albiez R, Monteiro RC, Rodriguez M, Binder CJ, Shoenfeld Y. Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation. Clin Exp Immunol, 2009 Dec;158 Suppl 1:43-50. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19883423 |
| 2009 | Sillaber C, Herrmann H, Bennett K, Rix U, Baumgartner C, Böhm A, Herndlhofer S, Tschachler E, Superti-Furga G, Jäger U, Valent P. Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily. Eur J Clin Invest, 2009 Dec;39(12): 1098-109. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19744184 |
| 2009 | Superti-Furga G. A biomedical adventurers’ guide to navigating between careers in academia and industry. Nat Rev Mol Cell Biol, 2009 Dec;10(12):884-7. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19859061 |
| 2009 | von Schlieffen E, Oskolkova OV, Schabbauer G, Gruber F, Blüml S, Genest M, Kadl A, Marsik C, Knapp S, Chow J, Leitinger N, Binder BR, Bochkov VN. Multi-hit inhibition of circulating and cell-associated components of the toll-like receptor 4 pathway by oxidized phospholipids. Arterioscler Thromb Vasc Biol, 2009 Mar; 29(3):356-62. Epub 2008 Dec 26. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19112167 |
| 2009 | Winger JA, Hantschel O, Superti-Furga G, Kuriyan J. The structure of the leukemia drug imatinib bound to human quinine reductase 2 (NQO2). BMC Struct Biol, 2009 Feb;9:7. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19236722 |